Autolus Therapeutics (AUTL) Earnings Date & Reports
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more
AUTL is expected to report earnings to rise 24.67% to -22 cents per share on October 30
Q3'25
Est.
$-0.22
Q2'25
Beat
by $0.05
Q1'25
Est.
$-0.26
Q4'24
Beat
by $0.12
Q3'24
Missed
by $0.10
The last earnings report on August 12 showed earnings per share of -18 cents, beating the estimate of -23 cents. With 1.61M shares outstanding, the current market capitalization sits at 417.84M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AUTL showed earnings on August 12, 2025. You can read more about the earnings report here.